tb 500 long term: Frequently asked questions

The longest continuous TB-500 protocol in published literature is 24 weeks in a rodent cardiac model, which showed diminishing returns after week 16. Extending beyond 12 weeks may plateau rather than compound benefits. No study has demonstrated additive gains from continuous dosing past 16 weeks in any tissue type. Consider a 4-week washout and re-assessment before deciding to continue.

No tb-500 long term studies have tested repeated on/off cycles systematically. Veterinary protocols often use 6-week cycles with 8–12 week breaks, but that's based on clinical observation rather than controlled research. The biological rationale supports cyclical use. Allowing tissue to consolidate gains under mechanical load before re-initiating angiogenesis. But optimal timing remains speculative in 2026.

No. Tissue remodeling continues 4–8 weeks beyond your final injection due to sustained VEGF and HGF expression. Resume controlled mechanical loading during this window to preserve collagen alignment and vascular density. Immobilization during weeks 8–16 post-protocol negates most structural gains by month 6, based on equine tendon data.

For lyophilized TB-500, use a cooler with ice packs rated for −20°C (blue ice or gel packs frozen solid). Place the peptide vial in a sealed plastic bag inside the cooler to prevent condensation contact during temperature transition. Lyophilized peptides tolerate short-term temperature elevation to 0–4°C for 24–48 hours without significant degradation. The goal is preventing moisture exposure, not maintaining perfect −20°C. For reconstituted TB-500, use an insulated medical cooler designed for injectable medications (FRIO-style evaporative coolers or hard-shell coolers with cold packs). Keep temperature between 2–8°C throughout transport; any excursion above 10°C begins accelerating degradation.

Discard it. TB-500 stored at room temperature (20–25°C) for 8–12 hours loses approximately 10–15% potency. And you have no way to measure the actual degradation without laboratory analysis. The peptide may still show effects in research models, but you've introduced an uncontrolled variable that compromises data reliability. Researchers who attempt to salvage room-temperature-exposed peptides often see inconsistent results across subsequent experiments. The loss isn't uniform across the vial, making every draw unpredictable. Replace the vial and adjust your protocol to prevent future temperature excursions.

If the vial remained sealed and you catch it within 24 hours, refrigerate immediately and use it as reconstituted peptide (28-day window starting now). If the vial sat at room temperature for more than 24 hours, or if you don't know how long it was thawed, discard it. Lyophilized TB-500 that undergoes uncontrolled thawing absorbs atmospheric moisture, which initiates hydrolysis even if the peptide appears dry. Visual inspection is useless here. Moisture content at the molecular level determines stability, and that requires specialized equipment to measure. Most peptide suppliers recommend discarding any lyophilized product exposed to uncontrolled thawing rather than risk using compromised material.